Topic 10: Biotechnology — Genetic Engineering, GM Crops & Gene Editing
Biotechnology is a top GS-III science area — it links to agriculture, health, industry & ethics. This file covers the basics of DNA, genes & genetic engineering, the key tools (recombinant DNA, PCR, gene cloning, CRISPR-Cas9 gene editing), GM crops (Bt cotton, Bt brinjal, GM mustard, golden rice), medical biotechnology (recombinant vaccines, insulin, gene & stem-cell therapy, monoclonal antibodies), industrial & environmental biotech, the bio-economy & BioE3 policy, and bioethics, biosafety & regulation (GEAC) — with labelled diagrams, tables and real dated PYQs with full model answers.
On this page
- 1.Biotechnology Basics
- 2.Genetic Engineering Tools
- 3.CRISPR & Gene Editing
- 4.GM Crops & Agriculture
- 5.Medical Biotechnology
- 6.Stem Cells & Gene Therapy
- 7.Industrial & Environmental
- 8.Bio-economy & Policy
- 9.Bioethics, Biosafety & Regulation
- 10.Current Affairs Link
- 11.Prelims PYQs
- 12.Mains PYQs + Model Answers
- ★15-Minute Revision Box
Conceptual Clarity — How UPSC Tests Biotechnology
Biotech is a high-frequency, high-scoring area straddling science, agriculture, health & ethics. Sort your prep into three question-types:
- Definitional / static — "what is recombinant DNA?", "what does CRISPR do?", "what is Bt in Bt cotton?". Recall of tools, techniques & terms.
- Statement-elimination — GM-crop approvals, gene-editing mechanisms, vaccine types where one detail decides the answer.
- Applied / current — a technology or regulation in the news (GM mustard, gene-edited crops, BioE3) linked to a fundamental — the strong GS-III bridge (food security, health, ethics).
Highest-frequency themes: recombinant DNA & PCR · CRISPR-Cas9 · Bt cotton/brinjal & GM mustard · golden rice · stem cells & gene therapy · monoclonal antibodies · GEAC & biosafety · bio-economy/BioE3.
1. Biotechnology Basics
- Biotechnology = using living organisms (or their parts — cells, enzymes, genes) to make useful products or processes — from ancient fermentation (curd, bread) to modern genetic engineering.
- DNA → gene → protein: genes (segments of DNA) carry instructions to make proteins that decide an organism's traits (Topic 4). Manipulating genes lets us change traits.
- Types: red (medical), green (agriculture), white (industrial), blue (aquatic/marine) biotechnology.
- Genetic engineering = deliberately altering an organism's DNA — adding, removing or editing genes to give a desired trait (a "genetically modified organism", GMO).
2. Genetic Engineering Tools
| Tool | What it does |
|---|---|
| Restriction enzymes | "Molecular scissors" that cut DNA at specific sequences |
| DNA ligase | "Molecular glue" that joins DNA fragments |
| Vectors (plasmids) | Carry the new gene into a host cell |
| PCR | Polymerase Chain Reaction — makes millions of copies of a DNA segment (used in diagnosis, e.g. RT-PCR for COVID) |
| Gene cloning | Producing identical copies of a gene or organism |
3. CRISPR & Gene Editing
- CRISPR-Cas9 is a precise, cheap gene-editing tool — a guide RNA locates a target DNA sequence and the Cas9 enzyme cuts it, letting scientists disable, correct or insert genes. (Nobel Prize 2020.)
- Unlike older GM (which adds foreign genes), gene editing can tweak an organism's own genes — sometimes leaving no foreign DNA (site-directed nuclease SDN-1/2 edits).
- Uses: disease-resistant & climate-resilient crops, treating genetic disorders (sickle cell), research. India has exempted certain gene-edited (SDN-1/SDN-2) plants from strict GM rules to speed research.
4. GM Crops & Agriculture
| Crop | Trait / status in India |
|---|---|
| Bt cotton | Carries Bacillus thuringiensis gene for pest (bollworm) resistance — the only GM crop commercially grown in India (since 2002). |
| Bt brinjal | Pest-resistant brinjal — approved by GEAC but placed under a moratorium in India; grown in Bangladesh. |
| GM (DMH-11) mustard | Hybrid mustard using barnase/barstar genes — got environmental clearance; under legal & public debate. |
| Golden Rice | Rice engineered to produce beta-carotene (Vitamin A) — aimed at fighting Vitamin-A deficiency. |
5. Medical Biotechnology
- Recombinant products: human insulin, growth hormone & clotting factors made in engineered bacteria/yeast — safer & cheaper than animal sources.
- Recombinant & new-platform vaccines: Hepatitis-B (recombinant), DNA/mRNA & vector vaccines (Topic 5) — faster to design.
- Monoclonal antibodies (mAbs): lab-made antibodies targeting one antigen — used in cancer, autoimmune disease & COVID therapy.
- Molecular diagnostics: PCR, RT-PCR & genetic tests for early, accurate disease detection.
6. Stem Cells & Gene Therapy
- Stem cells are unspecialised cells that can divide & become different cell types. Embryonic (pluripotent), adult (multipotent) & induced pluripotent (iPSC) — adult cells reprogrammed to stem-like state.
- Uses: regenerative medicine, bone-marrow transplant, tissue repair, research & drug testing.
- Gene therapy = treating a disease by correcting or replacing a faulty gene — somatic (body cells, not inherited) vs germline (heritable, ethically restricted).
- CAR-T cell therapy (engineered immune cells) treats some cancers; India has developed its own CAR-T therapy.
7. Industrial & Environmental Biotechnology
| Area | Examples |
|---|---|
| Industrial (white) | Enzymes in detergents & food, biofuels (ethanol), bio-plastics, fermentation products |
| Environmental | Bioremediation (microbes cleaning oil/heavy-metal pollution), sewage treatment, biofertilisers & biopesticides |
| Bio-energy | Ethanol blending, biogas, algal biofuel — links to clean energy |
| Bio-based materials | Bioplastics & bio-manufacturing to cut fossil dependence |
8. Bio-economy & Policy
- Bio-economy = economic activity from biological resources & biotech (pharma, agri-biotech, bio-industry, bio-services). India's bio-economy has grown rapidly to a multi-hundred-billion-dollar target.
- BioE3 Policy ("Biotechnology for Economy, Environment & Employment") promotes bio-manufacturing, bio-foundries & high-value bio-based products for sustainable growth.
- Department of Biotechnology (DBT) & BIRAC fund research & startups; missions on genome (Genome India), vaccines & bio-manufacturing.
9. Bioethics, Biosafety & Regulation
- GEAC (Genetic Engineering Appraisal Committee, under MoEFCC) is the apex body approving GM organisms & large-scale releases in India.
- Biosafety concerns: gene flow to wild/native species, effect on non-target insects & biodiversity, herbicide overuse, corporate seed control, and unknown long-term effects.
- Bioethics: germline editing & "designer babies", consent & equity in gene therapy, patenting of life, and biosafety of gain-of-function research.
- Biosecurity: risk of misuse of pathogens/biotech (bioweapons) — governed by the Biological Weapons Convention.
10. Current Affairs Link (2024–2026)
Biotech is a fast-moving news area spanning agriculture, health & policy. Verify the latest before the exam. check for latest update or data
| Recent theme | Fundamental it tests | Why it matters for UPSC |
|---|---|---|
| Gene-edited crops / GM mustard | Gene editing / GM | GS-III food security & ethics. |
| BioE3 & bio-manufacturing | Bio-economy | GS-III economy & jobs. |
| CAR-T & gene therapy | Medical biotech | GS-III health. |
| Genome India | Genomics | GS-III precision health. |
- Recurring exam hooks: CRISPR · Bt cotton/brinjal & GM mustard · golden rice · monoclonal antibodies · stem cells & CAR-T · GEAC · BioE3 & bio-economy.
11. Prelims PYQs
Objective questions anchored to genuinely tested UPSC themes on biotechnology. Each carries a worked rationale.
Q: Which is the only genetically modified crop grown commercially in India?
Answer: (b) Bt cotton (since 2002) is the only GM crop under commercial cultivation in India; Bt brinjal is under moratorium and GM mustard is still contested.
Q: CRISPR-Cas9 technology is used for —
Answer: (b) CRISPR-Cas9 uses a guide RNA and the Cas9 enzyme to cut DNA at a target site, enabling precise gene editing (Nobel 2020). PCR amplifies DNA.
Q: The Polymerase Chain Reaction (PCR) is primarily used to —
Answer: (c) PCR amplifies a DNA segment into millions of copies; RT-PCR is widely used in diagnostics (e.g. COVID-19).
Q: The "Bt" in Bt cotton refers to a gene sourced from —
Answer: (a) Bt crops carry a gene from Bacillus thuringiensis that produces a protein toxic to specific pests, giving in-built insect resistance.
Q: Golden Rice is genetically engineered to be rich in —
Answer: (b) Golden Rice produces beta-carotene, which the body converts to Vitamin A, to tackle Vitamin-A deficiency and blindness.
Q: In India, the apex body that approves the release of genetically modified organisms is the —
Answer: (b) The Genetic Engineering Appraisal Committee (GEAC), under the environment ministry, approves large-scale use & release of GMOs in India.
Q: Induced pluripotent stem cells (iPSCs) are produced by —
Answer: (b) iPSCs are adult cells reprogrammed to behave like embryonic stem cells, avoiding the ethical issues of embryonic stem cells.
Q: Monoclonal antibodies are —
Answer: (a) Monoclonal antibodies are lab-made, identical antibodies that bind one specific antigen — used in cancer, autoimmune & infectious-disease therapy.
Likely: CRISPR vs PCR vs recombinant DNA · Bt cotton/brinjal & GM mustard · golden rice · stem-cell types & CAR-T · monoclonal antibodies · GEAC · BioE3 & bio-economy. check for latest update or data
12. Mains PYQs + Model Answers
Biotechnology anchors GS-III questions on agriculture, health, economy & ethics. The frameworks below show how to deploy it analytically.
Q: Discuss the potential and concerns of genetically modified crops in ensuring India's food security.
Model Answer
- Introduction: GM crops (Section 4) engineer traits like pest resistance & nutrition to raise yields — a contested tool for food security.
- Potential:
- Higher yields & lower pesticide use (Bt cotton); nutrition (golden rice); climate/pest resilience; reduced import dependence (edible oils via GM mustard).
- Concerns: biosafety & gene flow, effect on biodiversity & non-target insects, herbicide overuse, corporate seed monopoly & farmer dependence, and public trust.
- Way forward: a robust, transparent GEAC process, case-by-case science-based assessment, labelling, public participation & support for indigenous seeds.
- Conclusion: GM can aid food & nutrition security if paired with strong biosafety, regulation & farmer interest.
Q: Gene-editing technologies like CRISPR promise a revolution but raise ethical questions. Examine.
Model Answer
- Introduction: CRISPR-Cas9 (Section 3) enables cheap, precise editing of genes — transformative for medicine & agriculture.
- Promise:
- Curing genetic disorders (sickle cell), disease/climate-resilient crops, faster research, and precision health.
- Ethical concerns: heritable germline editing & "designer babies", consent & equity of access, off-target effects, and biosecurity misuse.
- Governance: ban on germline editing, strong ethics review, regulatory clarity (SDN categories), and international norms.
- Conclusion: the gains are immense but must be guided by ethics, safety & equity so science serves humanity responsibly.
Q: How can biotechnology contribute to a sustainable bio-economy in India?
Model Answer
- Introduction: The bio-economy (Section 8) uses biological resources & biotech for growth, environment & jobs — India's BioE3 policy targets this.
- Contributions:
- Bio-manufacturing & bio-based materials replacing fossils; biofuels & biogas; biofertilisers & bioremediation; high-value pharma & agri-biotech.
- Enablers: DBT/BIRAC funding, startups, skilled talent & supportive regulation.
- Conclusion: a well-supported biotech sector can drive green, inclusive & self-reliant growth.
Q: Assess the role of biotechnology in improving India's healthcare, along with the regulatory challenges.
Model Answer
- Introduction: Medical biotech (Sections 5–6) has transformed diagnosis, drugs & therapy — from recombinant insulin to CAR-T.
- Healthcare gains:
- Recombinant vaccines & insulin; monoclonal antibodies; molecular diagnostics (RT-PCR); gene & stem-cell therapy; precision/genomic medicine (Genome India).
- Regulatory challenges: ethics of gene therapy & stem cells, unproven "stem-cell clinics", data privacy in genomics, affordability & access, and biosafety.
- Way forward: strong ethics & regulatory framework, indigenous affordable production, & equitable access.
- Conclusion: biotech can democratise quality healthcare if matched by robust, ethical regulation.
Likely: GM crops & food security · CRISPR ethics · bio-economy & BioE3 · biotech in healthcare · stem cells/gene therapy regulation · biosafety & GEAC. check for latest update or data
15-Minute Revision Box
Must-Remember Facts — Biotechnology
- Restriction enzyme = cut; ligase = join; vector/plasmid = carry gene
- PCR = amplify DNA (RT-PCR diagnostics)
- CRISPR-Cas9 = precise gene editing (guide RNA + Cas9, Nobel 2020)
- Gene editing edits own genes vs GM adds foreign gene
- Bt cotton = only GM crop commercial in India (2002)
- Bt brinjal = approved but moratorium; GM mustard (DMH-11) debated
- Golden rice = beta-carotene (Vitamin A)
- Bt = Bacillus thuringiensis pest-resistance gene
- Recombinant insulin/vaccines; monoclonal antibodies = single-target
- Stem cells: embryonic/adult/iPSC (iPSC avoids ethics)
- Gene therapy: somatic (safe) vs germline (banned)
- CAR-T = engineered T-cells vs cancer
- GEAC = approves GMOs in India
- BioE3 = biotech for Economy, Environment, Employment
- DBT/BIRAC fund R&D; Genome India = sequencing
- Concerns: biosafety, gene flow, germline ethics, biosecurity